Vivek N. Iyer, M.D., M.P.H. - Doctors ...

Dr. Vivek Iyer, MD

Claim this profile

Mayo Clinic

Studies Chronic Cough
Studies Hereditary Hemorrhagic Telangiectasia (HHT)
10 reported clinical trials
14 drugs studied

Affiliated Hospitals

Image of trial facility.

Mayo Clinic

Image of trial facility.

Marin General Hospital

Clinical Trials Vivek Iyer, MD is currently running

Image of trial facility.

Registry

for Hereditary Hemorrhagic Telangiectasia

The Comprehensive HHT Outcomes Registry of the United States (CHORUS) is an observational registry of patients diagnosed with Hereditary Hemorrhagic Telangiectasia (HHT). The purpose of this study is to better understand HHT, the symptoms and complications it causes, and the impact the disease has on people's lives. The investigators will collect long-term information about the participant, allowing us to understand how the disease changes over time, and what factors can influence those changes. Ultimately, this should help improve treatments for the disease. Another important goal of the study is to provide a way to contact people to participate in future clinical trials and other research. The registry will be a centralized resource for recruitment for clinical trials. People in the registry will not be obligated to join any of these additional studies, but if interested, can agree to be contacted if they may be eligible for a study. Participants will: * Be asked to provide permission to collect information from their medical records, including things like demographic information, diagnosis information, family history, test results, treatment information, symptoms, complications, lifestyle and other relevant medical information. * Be asked study-related questions by phone or at a clinic visit. * Be asked study-related questions every year after enrollment for up to 10 years or until the study ends. A member of the study team will communicate with participants by phone or at clinic visits to collect information regarding any changes to their health over the previous year/s including new test results, treatment information, symptoms, and complications from HHT.

Recruiting

1 award

N/A

2 criteria

Image of trial facility.

Duloxetine and Amitriptyline

for Refractory Chronic Cough

This trial is testing whether Amitriptyline and Duloxetine can help people who have a chronic cough that hasn't improved with other treatments. These medications are usually used for depression and anxiety but might also reduce coughing by changing how the brain processes signals. The study involves different doses to see which works best. Amitriptyline is an antidepressant used for various neurological conditions, including chronic cough, while Duloxetine is known for its efficacy in treating pain and anxiety symptoms.

Recruiting

2 awards

Phase 2

7 criteria

More about Vivek Iyer, MD

Clinical Trial Related

6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Vivek Iyer, MD has experience with

  • Amitriptyline
  • Duloxetine
  • Orvepitant Maleate
  • SyncAV Programmed ON
  • Fixed AV Delay
  • Catheter Ablation

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Vivek Iyer, MD specialize in?

Is Vivek Iyer, MD currently recruiting for clinical trials?

Are there any treatments that Vivek Iyer, MD has studied deeply?

What is the best way to schedule an appointment with Vivek Iyer, MD?

What is the office address of Vivek Iyer, MD?

Is there any support for travel costs?